oxtellarxrhcp.com
Patient Savings & Co-Pay Card - Oxtellar XR® (oxcarbazepine)
https://oxtellarxrhcp.com/patient-savings-resources
Patient Savings & Resources. Click here for Terms & Conditions. Patient Savings & Resources. These images are fictionalized for illustrative purposes only. Committed to Helping Your Patients Access the Medication They Need. Prescription reminders via text message. The ability to refill prescriptions via text message. Co-pay cards are designed so that the majority of commercially insured patients pay $0/month for up to 12 months. Patients can enroll here. DOWNLOAD CO-PAY CARDS FOR PATIENTS. Offer applies ...
oxtellarxrhcp.com
Important Safety Information – Oxtellar XR® (oxcarbazepine)
https://oxtellarxrhcp.com/important-safety-information
Patient Savings & Resources. Oxtellar XR is contraindicated in patients with a known hypersensitivity to oxcarbazepine or to any of its components. Inform patients who have had hypersensitivity reactions to carbamazepine that approximately 25% to 30% of them will experience hypersensitivity reactions with Oxtellar XR. Patients with a history of hypersensitivity reactions to carbamazepine should ordinarily be treated with Oxtellar XR only if the potential benefit justifies the potential risk. Disc...Serio...
oxtellarxrhcp.com
Site Map - Oxtellar XR® (oxcarbazepine)
https://oxtellarxrhcp.com/site-map
Patient Savings & Resources. Click here for Terms & Conditions. These images are fictionalized for illustrative purposes only. Patient Savings & Resources. Oxtellar XR is contraindicated in patients with a known hypersensitivity to oxcarbazepine or to any of its components. Inform patients who have had hypersensitivity reactions to carbamazepine that approximately 25% to 30% of them will experience hypersensitivity reactions with Oxtellar XR. Patients with a history of hypersensitivity reactions to c...
oxtellarxrhcp.com
Dosing & Administration – Oxtellar XR® (oxcarbazepine)
https://oxtellarxrhcp.com/dosing
Patient Savings & Resources. Click here for Terms & Conditions. These images are fictionalized for illustrative purposes only. Dosing Options for Adult and Pediatric Patients 6 Years of Age and Older. Oxtellar XR should be taken as a single daily dose on an empty stomach. Patients should take Oxtellar XR at least 1 hour before or at least 2 hours after meals. When Oxtellar XR is taken with food, adverse reactions are more likely to occur because of increased peak plasma concentration levels. Oxtellar XR ...
oxtellarxrhcp.com
Mechanism of Action - Oxtellar XR® (oxcarbazepine)
https://oxtellarxrhcp.com/efficacy/mechanism-of-action
Patient Savings & Resources. Click here for Terms & Conditions. These images are fictionalized for illustrative purposes only. Solutrol is proprietary extended-release technology that uses a unique matrix to deliver Oxtellar XR evenly and at a controlled rate over a 24-hour period. Click on the video below for more information on how Solutrol technology works. Data on file. Supernus Pharmaceuticals, Inc. Rockville, MD. Rare cases of anaphylaxis and angioedema involving the larynx, glottis, lips, and eyel...
oxtellarxrhcp.com
PROSPER Clinical Trial – Oxtellar XR® (oxcarbazepine)
https://oxtellarxrhcp.com/clinical-trials
Patient Savings & Resources. Click here for Terms & Conditions. These images are fictionalized for illustrative purposes only. Was Evaluated in PROSPER, a Well-Controlled Trial of Refractory Partial Seizures in Patients with Epilepsy. Median percent change from baseline in partial seizure frequency per 28 days for the 16 week treatment period. Median percentage change from baseline in partial seizure frequency per 28 days during the 12 week maintenance phase. 50% reduction in partial seizure frequency.
oxtellarxrhcp.com
Efficacy & Adverse Reactions - Oxtellar XR® (oxcarbazepine)
https://oxtellarxrhcp.com/efficacy
Patient Savings & Resources. Click here for Terms & Conditions. These images are fictionalized for illustrative purposes only. Powerful, Established Efficacy with Oxtellar XR. Clinically significant partial seizure reduction and partial seizure freedom rates in the 2400 mg group. Reduction = median percentage reduction, treatment phase, as adjunctive therapy in controlled phase 3 clinical trial in refractory epilepsy. Abbreviation: ITT, intent to treat. Cognitive adverse events were similar to placebo.